Fetal Growth Abnormality Clinical Trial
Official title:
Serial Third Trimester Abdominal Circumference and Amniotic Fluid Measurements Versus Routine Care: A Randomized Controlled Trial (STAR Trial)
The purpose of this study us to compare the rate of prenatal identification of abnormal fetal growth or amniotic fluid between clinical evaluation of uterine size by symphysis fundal height (SFH) measurements versus point-of-care ultrasound (POC-US) evaluation of abdominal circumference (AC) and maximum vertical pocket (MVP).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03230162 -
Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment
|
Phase 3 | |
Completed |
NCT03962153 -
Ultrasonographic Parameters for Fetal Weight Prediction
|
||
Completed |
NCT03266198 -
Fetal 3D Study (Fetal Body Composition and Volumes Study)
|